Musculoskeletal desmoid tumors

Journal of the American Academy of Orthopaedic Surgeons

Volumn 16, Issue 4, 2008, Pages 188-198

  Hosalkar, Harish S ^a   Torbert, Jesse T ^a   Fox, Edward J ^a   Delaney, Thomas F ^b   Aboulafia, Albert J ^c   Lackman, Richard D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42449163955     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-200804000-00002     Document Type: Article

References (65)

1. MacFarlane J: Clinical Reports of the Surgical Practice of the Glasgow Royal Infirmary. Glasgow, Scotland: Robertson, 1832, pp 63-66.
2. Shih HA, Hornicek FJ, DeLaney TF, Harmon DC, Suit HA: Fibromatosis: Current strategies for treatment.Curr Opin Orthop 2003;14:405-412.
3. Muller J: Ueber den feinern Bau und die Formen der krankhaften. Geschwulste, 1838.
4. Micke O, Seegenschmiedt MH: Radiation therapy for aggressive fibromatosis (desmoid tumors|: Results of a national Patterns of Care Study.Int J Radiat Oncol Biol Phys 2005;61:882-891.
5. Griffioen G, Bus PJ, Vasen HF, et al: Extracolonic manifestations of familial adenomatous polyposis: Desmoid tumours, and upper gastrointestinal adenomas and carcinomas.Scand J Gastroenterol Suppl 1998;225:85-91.
6. Bertario L, Russo A, Sala P, et al: Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.J Clin Oncol 2003;21:1698-1707.
7. Clark SK, Phillips RK: Desmoids in familial adenomatous polyposis.Br J Surg 1996;83:1494-1504.
8. Alman BA, Li C, Pajerski ME, et al: Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).Am J Pathol 1997;151:329-334.
9. Giarola M, Wells D, Mondini P, et al: Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours.Br J Cancer 1998;78:582-587.
10. Dormans JP, Spiegel D, Meyer J, et al: Fibromatoses in childhood: The desmoid/fibromatosis complex.Med Pediatr Oncol 2001;37:126-131.
11. Alman BA, Goldberg MJ, Naber SP, et al: Aggressive fibromatosis.J Pediatr Orthop 1992;12:1-10.
12. Kong Y, Poon R, Nadesan P, et al: Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.Cancer Res 2004,64: 5795-5803.
13. Church JM, McGannon E: Prior pregnancy ameliorates the course of intraabdominal desmoid tumors in patients with familial adenomatous polyposis.Dis Colon Rectum2000;-43:445-450.
14. Goy BW, Lee SP, FU YS, Selch MT, Eilber F: Treatment results of unresected or partially resected desmoid tumors.Am J Clin Oncol 1998;21: 584-590.
15. Dalén BP, Bergh PM, Gunterberg BU: Desmoid tumors: A clinical review of 30 patients with more than 20 years' follow-up.Acta Orthop Scand 2003; 74:455-459.
16. Dalén BP, Geijer M, Kvist H, Bergh PM, Gunterberg BU: Clinical and imaging observations of desmoid tumors left without treatment.Am J Clin Oncol 1998;21:584-590.
17. Abramowitz D, Zornoza J, Ayala AG,et al: Soft-tissue desmoid tumors: Radiographic bone changes.Radiology 1983;146:11-13.
18. Tanaka H, Harasawa A, Furui S: Usefulness of MR imaging in assessment of tumor extent of aggressive fibromatosis.Radiat Med 2005;23:111-115.
19. Liu P, Thorner P: MRI of fibromatosis: With pathologic correlation.Pediatr Radiol 1992;22:587-589.
20. Vandevenne JE, De Schepper AM, De Beuckeleer L, et al: New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions.Eur Radiol 1997;7:1013-1019.
21. Sundaram M, Duffrin H, McGuire MH, et al: Synchronous multicentric desmoid tumors (aggressive fibromatosis) of the extremities.Skeletal Radiol 1988;17:16-19.
22. Weiss SW, Goldblum JR: Fibromatosis, in Enzinger and Weiss (eds):Soft Tissue Tumors. Philadelphia, PA: Mosby, 2001.
23. Leithner A, Gapp M, Radl R, et al: Immunohistochemical analysis of desmoid tumours.J Clin Pathol 2005; 58:1152-1156.
24. Dal Cin P, Sciot R, Aly MS, et al: Some desmoid tumors are characterized by trisomy 8.Genes Chromosomes Cancer 1994;10:131-135.
25. Mertens F, Willen H, Rydholm A, et al: Trisomy 20 is a primary chromosome aberration in desmoid tumors.Int J Cancer 1995;63:527-529.
26. Fletcher JA, Naeem R, Xiao S, et al: Chromosome aberrations in desmoid tumors: Trisomy 8 may be a predictor of recurrence.Cancer Genet Cytogenet 1995;79:139-143.
27. Kouho H, Aoki T, Hisaoka M, et al: Clinicopathological and interphase cytogenetic analysis of desmoid tumours.Histopathology 1997;31:336-341.
28. Skubitz KM, Skubitz AP: Characterization of sarcomas by means of gene expression.J Lab Clin Med 2004; 144: 78-91.
29. Gronchi A, Casali PG, Mariani L, et al: Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution.J Clin Oncol 2003;21:1390-1397.
30. Park HC, Pyo HR, Shin KH, et al: Radiation treatment for aggressive fibromatosis: Findings from observed patterns of local failure.Oncology 2003; 64:346-352.
31. Schulz-Ertner D, Zierhut D, Mende U, et al: The role of radiation therapy in the management of desmoid tu-mors.Strahlenther Onkol 2002; 178: 78-83.
32. Zlotecki RA, Scarborough MT, Morris CG, et al: External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis.Int J Radiat Oncol Biol Phys 2002;54:177-181.
33. Sorensen A, Keller J, Nielsen OS, et al: Treatment of aggressive fibromatosis: A retrospective study of 72 patients followed for 1-27 years.Acta Orthop Scand 2002;73:213-219.
34. Jelinek JA, Stelzer KJ, Conrad E, et al: The efficacy of radiotherapy as postoperative treatment for desmoid tumors.Int J Radiat Oncol Biol Phys 2001;50:121-125.
35. Merchant NB, Lewis JJ, Woodruff JM, et al: Extremity and trunk desmoid tumors: A multifactorial analysis of outcome.Cancer 1999;86:2045-2052.
36. Spear MA, Jennings LC, Mankin HJ, et al: Individualizing management of aggressive fibromatoses.Int J Radiat Oncol Biol Phys 1998;40:637-645.
37. Ballo MT, Zagars GK, Pollack A: Radiation therapy in the management of desmoid tumors.Int J Radiat Oncol Bio1 Phys 1998;42:1007-1014.
38. Nuyttens JJ, Rust PF, Thomas CR Jr, et al: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles.Cancer 2000;88:1517-1523.
39. Enzinger FM, Shiraki M: Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid): Analysis of thirty cases followed up for ten or more years.Cancer 1967;20:1131-1140.
40. Rock MG, Pritchard DJ, Reiman HM, et al: Extra-abdominal desmoid tumors.J Bone Joint Surg Am 1984;66: 1369-1374.
41. Schmitt G, Mills EE, Levin V, Smit BJ, Boecker H, Pape H: Radiotherapy of aggressive fibromatosis.Eur J Cancer 1992;28A:832-835.
42. Acker JC, Bossen EH, Halperin EC: The management of desmoid tumors.Int J Radiat Oncol Biol Phys 1993;26:851-858.
43. Janinis J, Patriki M, Vini L, et al: The pharmacological treatment of aggressive fibromatosis: A systematic review.Ann Oncol 2003;14:181-190.
44. Weiss AJ, Lackman RD: Low-dose chemotherapy of desmoid tumors.Cancer 1989;64:1192-1194.
45. Wehl G, Rossler J, Otten JE, et al: Response of progressive fibromatosis to therapy with liposomal doxorubicin.Onkologie 2004;27:552-556.
46. Poritz LS, Blackstein M, Berk T, et al: Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors.Dis Colon Rectum 2001;44:1268-1273.
47. Azzarelli A, Gronchi A, Bertulli R, et al: Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.Cancer 2001;92:1259-1264.
48. Skapek SX, Hawk BJ, Hoffer FA, et al: Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.J Clin Oncol 1998; 16:3021-3027.
49. Schnitzler M, Cohen Z, Blackstein M, et al: Chemotherapy for desmoid tumors in association with familial adenomatous polyposis.Dis Colon Rectum 1997;40:798-801.
50. Patel SR, Evans HL, Benjamin RS: Combination chemotherapy in adult desmoid tumors.Cancer 1993;72: 3244-3247.
51. Hansmann A, Adolph C, Vogel T, et al: High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.Cancer 2004;100:612-620.
52. Okuno SH, Edmonson JH: Combination chemotherapy for desmoid tumors.Cancer 2003;97:1134-1135.
53. Weiss AJ, Lackman RD: Therapy of desmoid tumors and related neoplasms.Compr Ther 1991;17:32-34.
54. Weiss AJ, Horowitz S, Lackman RD: Therapy of desmoid tumors and fibromatosis using vinorelbine.Am J Clin Oncol 1999;22:193-195.
55. Kono T, Tomita I, Chisato N, et al:Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: Report of a case.Dis Colon Rectum 2004;47: 246-249.
56. Dresdale A, Bonow RO, Wesley R, et al: Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft-tissue sarcomas. Cancer 1983;52:51-60.
57. Stein R: Chemotherapeutic response in fibromatosis of the neck. J Pediatr 1977;-90:482-483.
58. Seiter K, Kemeny N: Successful treatment of a desmoid tumor with doxorubicin. Cancer 1993;71:2242-2244.
59. Reitamo JJ, Hayry P, Nykyri E, et al: The desmoid tumor: I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665-673.
60. Tsukada K, Church JM, Jagelman DG, et al: Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 1992; 35:29-33.
61. Poon R, Smits R, Li C, et al: Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 2001;20:451-460.
62. Patel SR, Benjamin RS: Desmoid tumors respond to chemotherapy: Defying the dogma in oncology. J Clin Oncol 2006;24:11-12.
63. Mace J, Sybil Biermann J, Sondak V, et al: Response of extraabdominal desmoid tumors to therapy with imat-inib mesylate. Cancer 2002;95:2373-2379.
64. De Pas T, Bodei L, Pelosi G, et al: Peptide receptor radiotherapy: A new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group. Br J Cancer 2003,-88: 645-647.
65. Clark TW: Percutaneous chemical ablation of desmoid tumors. J Vasc Interv Radiol 2003;14:629-634.